About Getwell Oncology Private Limited
Data last updated:
Getwell Oncology Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 March 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85191DL2010PTC200011. Its GSTIN is 07AADCG7485R1ZP (Delhi). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manas Tandon and Mini Tandon.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No 721, Sector 19 Pocket 3, Delhi, India – 110075.
As per the financials filed for FY 2024, the company reported a revenue of ₹57,377, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹4.49 Lakh and EBITDA of -₹16,923 (EBITDA margin -29.5%). Revenue has declined at a compounded annual rate (CAGR) of 84% over three years and 74% over five years.
The company has about 11 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website getwelloncology.com.
Company details
Contact details
Getwell Oncology Private Limited's registered office is in Delhi, Delhi. Its website is getwelloncology.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFlat No 721, Sector 19 Pocket 3, Delhi, India – 110075
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Getwell Oncology Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Getwell Oncology is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Getwell Oncology Private Limited, buy the company report.
Financials of Getwell Oncology Private Limited
FY 2024 filings availableGetwell Oncology Private Limited reported revenue of ₹57,377 (up 258% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 258% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 74%. EBITDA rose 96% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹57,377 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹16,923 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.49 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -29.5% | ||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Getwell Oncology Private Limited, buy the company report.
Board of directors of Getwell Oncology Private Limited
Getwell Oncology has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manas Tandon | Director | 12 Mar 2010 | 16 Years 7 Months | Current |
| Mini Tandon | Director | 12 Mar 2010 | 16 Years 7 Months | Current |
Auditor
Getwell Oncology Private Limited is audited by DSP & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DSP & Associates | FY 2024 | 006791N |
Shareholding
The shareholding of Getwell Oncology Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Getwell Oncology Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Getwell Oncology Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Getwell Oncology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Getwell Oncology Private Limited has a workforce of 11 employees on its EPFO records as of Mar 08, 2025, across 1 active EPFO establishment.
GST
Getwell Oncology has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCG7485R1ZP | Delhi | Active | 01 Jul 2017 |
| 06AADCG7485R2ZQ | Haryana | Active | 01 Sep 2018 |
To see the full GST registrations and return filing status of Getwell Oncology Private Limited, buy the company report.
Recent activity
Getwell Oncology Private Limited has 3 board changes on record since 2010: 2 appointments and 1 cessation. The latest: Rajiv Tandon ceased to be Director on 25 Jan 2022.
Frequently asked questions
Getwell Oncology is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 March 2010 (16+ years old) and is registered under CIN U85191DL2010PTC200011.
Getwell Oncology has 2 current directors:
- Manas Tandon - Director
- Mini Tandon - Director
The latest financial statements of Getwell Oncology on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Getwell Oncology is 07AADCG7485R1ZP, registered in Delhi. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 06AADCG7485R2ZQ (Haryana).
The CIN (Corporate Identification Number) of Getwell Oncology is U85191DL2010PTC200011. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Getwell Oncology was incorporated on 12 March 2010, making it 16+ years old. It is registered with the Registrar of Companies, Delhi.
Rajiv Tandon ceased to be Director on 25 Jan 2022. Manas Tandon was appointed as Director on 12 Mar 2010. Mini Tandon was appointed as Director on 12 Mar 2010.
Getwell Oncology can be reached through the website getwelloncology.com. Its registered office is in Delhi, India.
The registered office of Getwell Oncology is at Flat No 721, Sector 19 Pocket 3, Delhi, India – 110075.
Getwell Oncology operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
